Stay updated on Sitravatinib Combo vs Docetaxel in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib Combo vs Docetaxel in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib Combo vs Docetaxel in Lung Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T14:58:17.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A site-wide NIH announcement says the agency is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to transition updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T14:00:50.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T15:15:11.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The site footer revision number changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T15:09:42.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content with an error screen. The prior study details and related sections are no longer visible.
    Difference
    16%
    Check dated 2026-09-20T22:35:28.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The study page adds a site in Coeur d'Alene, Idaho, and updates multiple data-collection time windows (e.g., post-dose follow-ups for safety and efficacy, progression assessments, and patient-reported outcomes). These changes reflect revised conduct details for the trial and affect how and over what period outcomes are measured.
    Difference
    0.3%
    Check dated 2026-09-13T21:51:11.000Z thumbnail image

Stay in the know with updates to Sitravatinib Combo vs Docetaxel in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo vs Docetaxel in Lung Cancer Clinical Trial page.